Press Release Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile Aug 4
Press Release Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026 Jul 21